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 Abstract
On the basis of two cases we discuss the important issues regarding the sentinel lymph node detection biopsy 
(SLNB) in endometrial cancer with combined cervical administration of the radiocolloid and the subserosal blue dye 
injection.
The first patient (endometrioid adenocarcinoma G2, invasion >50% myometrium) had 4 SLNs detected. Three were 
both hot and blue (detected on SPECT-CT). The fourth, paraaortic SLN was blue only. None of the lymph nodes 
contained metatstases. 
The second patient (endometrioid adenocarcinoma G1, invasion >50% myometrium) had 4 SLNs detected. Three 
were blue (but two of them had also very low radioactivity). The fourth SLN was hot only. Blue only node contained 
macrometastasis. In the past patients underwent cervical amputation.
Diverse distribution of each tracer confirms the advantages of the combined tracers administration in SLNB. 
The radiotracer is the crucial component - uptake was present in 6 of 8 SLNs. Although the blue dye is more a 
complimentary method, its suberosal injection significantly increases the safety of the SLNB procedure. In the first 
case we have detected blue only SLN in paraaortic region which otherwise would be missed using the cervical 
approach only. More importantly, in the second case the tracer uptake was very limited due to the previous surgery 
and the blue dye administration allowed correct SLNs detection (including the metastatic node). 
Presented clinical cases confirms that the combined cervical and subserosal tracers administration together with 
preoperative SPECT-CT constitute an optimal SLN detection method and correctly provides information about the 
regional lymph node status.
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Introducion
The	endometrial	cancer	is	the	fourth	most	frequent	cancer	
in	women	in	Poland	with	4820	new	cases	in	2008	(1).	Moreover	
the	incidence	of	the	endometrial	cancer	is	still	increasing	–	the	
burden	of	treatment	will	be	even	more	important	in	future	[1].	
The	 sentinel	 lymph	 node	 biopsy	 (SLNB)	 has	 become	 a	
standard	 technique	 in	malignant	melanoma	 and	 breast	 cancer	
(2,3),	 in	gynecologic	oncology	 feasibility	 and	 safety	of	SLNB	
was	confirmed	 in	vulvar	cancer	 [4]	and	cervical	cancer	 [5,	6].	
The	first	report	on	SLNB	in	endometrial	cancer	was	published	
in	1996	by	Burke	et	al	[7].	In	a	recent	meta-analysis	of	26	studies	
on	SLNB	in	endometrial	cancer	in	1101	procedures	the	detection	
rate	and	the	sensivity	was	78%	and	93%	[8]	
There	 are	 two	 theoretical	 indications	 for	 SLNB	 in	
endometrial	cancer.	First	one	regards	the	patients	with	high	risk	
of	the	nodal	metastases	(serous	or	clear-cell	type,	grade	3,	more	
than	50%	of	myometrial	invasion).	In	this	group	radical	pelvic	
and	paraaortic	lymphadenectomy	is	indicated	but	in	cases	where	
no	 metastases	 are	 found	 this	 procedure	 provides	 no	 benefits	
for	 the	patient	and	only	 increases	 the	risk	of	 the	perioperative	
morbidity.	Thus	in	this	group	the	identification	of	negative	SLNs	
could	effect	in	abandoning	the	unnecessary	lymphadenectomy.	
Also	 in	 patients	with	 significant	 contraindications	 for	 surgery	
(e.g.	morbid	 obesity),	when	 the	 lymphadenectomy	will	 not	 be	
performed,	the	SLNB	might	be	the	alternative	for	lymph	node	
status	evaluation.	This	can	lead	to	better	postoperative	analysis	
of	indications	for	the	adjuvant	treatment.	
The	 second	 application	 of	 the	 SLNB	 regards	 the	 patients	
with	 low	 risk	 of	 the	 nodal	 metastases.	 There	 is	 a	 significant	
discrepancy	 between	 the	 preoperative/intraoperative	 and	
the	 final	 pathologic	 diagnosis.	 In	 two	 studies	 analyzing	 the	
concordance	of	the	preoperative	and	postoperative	pathological	
diagnosis,	the	tumor	grade	changed	from	the	grade	1	to	grade	2	
or	3	in	23-29%	of	cases	[9,	10].	
Case	 et	 al.	 compared	 the	 intraoperative	 frozen	 section	 to	
the	final	results	and	found	that	depth	of	invasion	and	the	tumor	
grade	was	 upstaged	 in	 28%	 and	 38%	 respectively	 [11].	 These	
data	 show	 that	 in	 some	cases	 the	 adequate	 surgical	 staging	 is	
not	 done	 although	 indicated.	 In	 such	 cases	 the	 SLNB	 would	
provide	information	about	the	nodal	status	and	help	to	determine	
adequate	further	treatment.	
Single-photon	emission	computed	 tomography	 fused	with	
computed	 tomography	 (SPECT-CT)	 is	 a	 nuclear	 medicine	
imaging	 technique	 providing	 three-dimensional	 image	 of	 the	
radioactive	agent	(nanocolloid-Tc99m)	distribution	imposed	on	
a	 tomographic	 scan.	 This	method	 allows	 precise	 preoperative	
localization	of	the	sentinel	lymph	nodes.	The	SPECT-CT	have	
been	recently	incorporated	in	the	sentinel	lymph	node	detection	
procedure	in	endometrial	cancer	[12].
In	 this	 paper	 we	 would	 like	 to	 present	 two	 interesting,	
representative	 cases	 in	which	we	 have	 performed	 the	 sentinel	
lymph	 node	 detection	 technique	 –	 on	 this	 basis	 the	 most	
important	issues	regarding	this	method	will	be	discussed.	
Material and methods
From	February	to	November	2011,	44	patients	with	biopsy	
proven	endometrial	cancer	were	included	in	a	prospective,	non-
randomized	study	analyzing	the	feasibility	of	SLNB.	From	this	
group	 two	 cases	 has	 been	 described.	 Inclusion	 criteria	 were:	
endometrial	cancer	(endometrioid,	clear	cell,	serous),	grade	1-3,	
no	evidence	of	disease	outside	the	corpus,	no	contraindications	
for	 the	 abdominal	 surgery.	Patients	with	prior	 radiotherapy	of	
the	pelvis	or	pelvic	lymphadenectomy	were	excluded.
Preoperative	 evaluation	 was	 based	 on	 physical	 and	
gynecological	 examination,	 chest	 x-ray,	 MRI,	 transvaginal	
ultrasound	 and	 routine	 laboratory	 tests.	 Therapeutic	 strategy	
was	based	on	the	presence	of	the	nodal	metastases	risk	factors.	
The	pelvic	and	paraaortic	lymphadenectomy	was	performed	in	
 Streszczenie
Na podstawie dwóch przypadków przedstawiono najważniejsze kwestie dotyczące techniki detekcji węzła 
wartowniczego (SLNB) w raku trzonu macicy przy zastosowaniu doszyjkowego podania radiokoloidu oraz 
podsurowicówkowego podania błękitu metylenowego.
U pierwszej pacjentki (gruczolakorak endometrialny G2, inwazja >50% mięśniówki) wykryto 4 SLN. Trzy były 
aktywne i niebieskie (potwierdzone w SPECT-TK), czwarty (przyaortalny) były tylko niebieski. W węzłach chłonnych 
nie stwierdzono przerzutów. 
U drugiej pacjentki (gruczolakorak endometria lny G2, inwazja >50% mięśniówki) wykryto 4 SLN. Trzy były tylko 
niebieskie (ale dwa posiadały również bardzo niską aktywność), czwarty był tylko aktywny. Jeden tylko niebieski 
SLN zawierał przerzuty. Pacjentka w przeszłości przeszła amputację szyjki macicy. 
Zróżnicowana dystrybucja znaczników potwierdza przydatność podania skojarzonego w detekcji SLN. Radiokoloid 
jest podstawową składową SLNB – aktywność wykryto w 6 z 8 wartowników. Mimo, że zastosowanie błękitu 
metylenowego stanowi metodę dodatkową, jego podanie podsurowicówkowe istotnie zwiększa bezpieczeństwo 
techniki. 
W pierwszym przypadku wykryto niebieski przyaortalny SLN, który nie został by wykryty przy podaniu doszyjkowym. 
Co więcej, w drugim przypadku, wychwyt radiololoidu był znacznie ograniczony z powodu amputacji szyjki 
macicy – podanie błękitu metylenowego umożliwiło wykrycie SLN (w tym jednego z przerzutami). Przedstawione 
przypadki potwierdzają, że skojarzona technika wykrywania SLN z podaniem doszyjkowym radiokoloidu oraz 
podsurowicówkowym błękitu i zastosowaniem SPECT-TK stanowi optymalna metodę detekcji i właściwie ocenia 
status regionalnych węzłów chłonnych.
 Słowa kluczowe: węzeł wartowniczy / rak trzonu macicy / limfoscyntygrafia / 
        / SPECT-TK / 
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case	 of:	 serous	 or	 clear-cell	 type,	 grade	 3,	more	 than	 50%	of	
myometrial	 invasion	 and	 cervical	 involvement.	 In	 remaining	
patients	(“low-risk”	group)	only	the	sentinel	lymph	node	biopsy	
was	 performed.	The	SLN	were	 submitted	 for	 the	 ultrastaging	
(200μm,	H&E,	AE1/3),	 all	 remaining	 lymph	nodes	 have	been	
submitted	for	the	routine	pathological	examination	(H&E).
The	 study	 was	 approved	 by	 the	 Medical	 University	 of	
Gdańsk	 Ethics	 Committee,	 all	 the	 patients	 signed	 informed	
consent	before	study	procedures.	
SLN detection technique
On	 the	 day	 of	 surgery	 in	 the	 Department	 of	 Nuclear	
Medicine	two	superficial	cervical	injections	of	the	Tc99m	labelled	
nanocolloid	were	administrated	(1ml,	0,5mCi,	Nano-Albumon,	
Medi-Radiopharma).	 After	 60	 minutes	 the	 SPECT-CT	 was	
performed.	 Any	 focal	 activity	 in	 the	 pelvis	 or	 abdomen	 was	
identified	as	a	potential	SLN.	During	 surgery,	 four	 subserosal	
injections	 to	 the	 uterine	 fundus	 were	 done	with	 the	 blue	 dye	
(Oterop	Methylenblau,	Sterop	Pharmacobel).	After	opening	the	
retroperitoneal	 space	 the	SLNs	were	detected	using	 the	hand-
held	 gamma	 probe	 (Neoprobe	 2000,	 Neoprobe	 Corporation)	
and	 direct	 visualization	 of	 the	 blue	 nodes.	 According	 to	 the	
intraoperative	findings	 the	SLNs	were	 labeled	as	“hot”	and/or	
“blue”.	 The	 definition	 for	 the	 detection	 of	 the	 SLNs	was:	 the	
activity	of	at	least	10-times	above	background	and/or	presence	
of	 the	 blue	 stained	 capsule	 or	 visible	 blue	 lymphatic	 vessels	
leading	directly	to	the	node.	
Case reports
Case no 1.
Women	 62	 years	 old,	 with	 diagnosis	 of	 endometrioid	
adenocarcinoma	G2.	Patient	had	no	comorbidities	nor	previous	
operations.	Patient’s	weight	was	68cm,	height	164cm	and	BMI	
25.3.	Preoperative	evaluation	revealed	tumor	invading	more	than	
50%	of	the	myometrium.	On	SPECT-CT	there	were	three	active	
sites:	right	external	iliac,	right	common	iliac	and	left	obturator	
(Figure	1).	
Patient	underwent	 total	 abdominal	hysterectomy,	bilateral	
salpingoophorectomy	and	pelvic/paraaortic	 lymphadenectomy.	
During	the	surgery	4	SLNs	were	detected.	Three	of	them	were	
both	 hot	 and	 blue,	 their	 localization	 corresponded	 with	 the	
preoperative	SPECT-CT:	right	external	iliac,	right	common	iliac	
and	 left	obturator.	All	3	SLNs	were	highly	active	 (app.	3000-
11000	cps),	the	background	activity	was	40-60	cps.	The	fourth	
SLN	was	only	blue	and	was	located	in	left	paraaortic	region.	
Pathological	 examination	 confirmed	 the	 preoperative	
diagnosis	 (endometrioid	 adenocarcinoma	 G2),	 the	 tumor	
infiltrates	more	than	50%	of	the	myometrium	and	extends	to	the	
cervical	canal,	there	were	no	nodal	metastases	(FIGO	II).	The	
total	number	of	resected	lymph	nodes	was	39	(19	pelvic	and	20	
paraaortic).	Peritoneal	cytology	was	negative.
Case no 2.
Women	 62	 years	 old,	 with	 diagnosis	 of	 endometrioid	
adenocarcinoma	 G1.	 Patient	 had	 arterial	 hypertension	 and	
underwent	cervical	amputation	due	to	pelvic	organ	prolapse	in	
the	past.	Patient’s	weight	was	78cm,	height	159cm	and	BMI	30.9.	
Preoperative	evaluation	revealed	tumor	invading	less	than	50%	
of	the	myometrium.	SPECT-CT	detected	no	active	sites.	
Figure 1. SPECT-CT scans of the detected sentinel lymph nodes in the first case. 
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Patient	underwent	 total	 abdominal	hysterectomy,	bilateral	
salpingoophorectomy	and	pelvic	lymphadenectomy.	During	the	
surgery	4	SLNs	were	detected.	Three	of	them	were	blue:	right	
external	 iliac,	 left	external	 iliac	and	 left	obturator.	The	 fourth	
SLN	was	hot	only	(app.	600	cps)	and	was	located	in	left	common	
iliac	 region.	After	 removing	 the	 lymph	nodes	 in	 two	 external	
iliac	blue	SLNs	also	a	very	low	activity	was	detected	(app.	200	
cps).	 The	 background	 activity	 was	 30-60	 cps,	 there	 was	 also	
unusual,	remarkably	low	parametrial	activity.	
Pathological	 examination	 diagnosed	 endometrioid	
adenocarcinoma	G2	 (upgraded	 in	 comparison	 to	 preoperative	
diagnosis),	 the	 tumor	 infiltrates	 more	 than	 50%	 of	 the	
myometrium	(the	involvement	of	the	outer	half	of	myometrium	
was	 found	 only	 on	microscopic	 evaluation).	 In	 one	 SLN	 (left	
obturator,	blue	only)	the	cancer	macrometastasis	was	found,	the	
remaining	lymph	nodes	were	negative	(FIGO	IIIC1).	The	total	
number	 of	 resected	 lymph	 nodes	was	 25.	 Peritoneal	 cytology	
was	negative.
Discussion
Presented	 cases	 allow	 to	 extensively	 discuss	 the	 most	
important	issues	regarding	the	SLNB	in	endometrial	cancer.	In	
general,	both	cases	confirm	the	feasibility	of	the	method	–	SLNs	
were	detected	bilaterally,	moreover	in	the	second	case	the	SLN	
was	metastatic.	
An	 important	 issue	 regarding	 the	 potential	 use	 of	 the	
SLNB	 in	 endometrial	 cancer	 regards	 the	 evaluation	 of	 the	
appropriate	 tracer	 injection	 site.	 It	 is	not	yet	 confirmed	which	
technique	 (cervical,	 histeroscopic	 or	 submucosal	 injections)	
would	precisely	reflect	the	lymphatic	drainage	from	the	tumor	
site.	 We	 have	 decided	 to	 include	 the	 cervical	 and	 subserosal	
tracers	administration	due	to	higher	detection	rates	reported	in	
the	literature	[8-10,	13].	In	a	recent	meta-analysis	of	1101	SLNB	
procedures	in	endometrial	cancer	the	superior	detection	rated	was	
related	with	the	cervical	injection	comparing	to	the	hysteroscopic	
approach	 [8].	 Robova	 et	 al.	 compared	 the	 hysteroscopic	 and	
subserosal	 tracers	 administration	 and	 obtained	 significantly	
lower	detection	 rate	with	 the	hysteroscopic	 injection	 (50%	vs.	
73,1%)	[13].
Diverse	distribution	of	each	tracer	in	our	two	cases	confirms	
the	advantages	of	 the	combined	cervical	administration	of	 the	
radiocolloid	and	the	subserosal	blue	dye	injection.	Most	important	
component	 of	 the	 SLN	 detection	 is	 the	 administration	 of	 the	
radiocolloid.	 It	 allows	 preoperative	 detection	 of	 the	 potential	
SLNs,	 during	 surgery	 SLNs	 are	 precisely	 located	 with	 the	
handheld	gamma-probe	before	tissue	preparation.	The	cervical	
way	of	administration	is	very	convenient	and	easy.	Its	accuracy	
has	been	already	confirmed	by	the	studies	on	SLNB	in	cervical	
cancer	[5,	6].	In	our	two	cases	the	radiotracer	uptake	was	present	
in	6	of	8	SLNs	(although	in	two	SLNs	with	insufficient	activity	
due	to	previous	cervical	surgery).	The	main	issue	regarding	this	
approach	is	whether	the	cervical	injection	adequately	corresponds	
with	the	lymphatic	drainage	from	the	uterine	corpus.	The	data	
from	 studies	 analyzing	 the	metastatic	 patterns	 in	 endometrial	
cancer	 suggest	 that	 in	most	of	 the	 cases	metastases	 are	 found	
in	 pelvic	 region	 and	 isolated	 paraaortic	 metastases	 are	 rare.	
Abu-Rustum	et	al.	described	the	incidence	of	isolated	paraaortic	
nodal	metastasis	in	patients	with	negative	pelvic	lymph	nodes.	
In	 the	 group	 of	 734	 patients	with	 negative	 pelvic	 nodes	 there	
were	only	12	cases	(1.6%)	with	positive	paraaortic	nodes	[14].	In	
similar	study	Hirahatake	et	al.	evaluated	the	incidence	of	lymph	
nodes	metastases	 in	 a	group	of	200	patients	with	 endometrial	
cancer.	 Pelvic	 lymph	node	metastases	were	 observed	 in	 20%,	
paraaortic	lymph	node	metastasis	were	found	in	9%.	In	analyzed	
group	in	88,9%	of	the	cases	of	positive	paraaortic	metastases	the	
pelvic	nodes	were	also	involved.	Only	in	two	cases	(2/200)	there	
were	isolated	paraaortic	metastases	(1%)	[15].	
Those	data	suggest	that	in	endometrial	cancer	the	paraaortic	
metastases	mostly	derive	from	the	pelvic	metastases.
In	order	 to	detect	 potential	SLNs	 in	paraaortic	 region	we	
decided	to	administrate	the	blue	dye	superficially	to	the	uterine	
fundus.	The	cervical	injection	of	the	blue	dye	would	double	the	
radiocolloid	nodal	uptake,	resulting	only	in	better	visualization	
of	the	SLNs.	
Although	 the	 blue	 dye	 administration	 is	 rather	 a	
complimentary	 method	 in	 SLNB	 its	 suberosal	 injection	
significantly	 increases	 the	 safety	of	 the	procedure.	 In	 the	first	
case	 we	 have	 detected	 blue	 only	 SLN	 in	 paraaortic	 region,	
which	otherwise	would	be	missed	using	the	cervical	approach	
only.	More	 importantly,	 in	 the	 second	 case	 the	 tracer	 uptake	
was	very	limited	due	to	the	previous	surgery	and	the	blue	dye	
administration	 allowed	 correct	 SLNs	 detection	 (including	 the	
metastatic	node).	
The	intraoperative	detection	of	the	blue	only	SLN	is	difficult	
when	 the	node	 is	not	 located	 just	under	 the	peritoneum.	From	
our	 experience,	 in	most	 cases	 it	 is	 possible	 to	 find	 very	 fine,	
intensively	blue,	lymphatic	vessels	leading	directly	to	the	SLN	
–	this	allows	SLN	detection	even	in	obturator	fossa	or	high	in	
paraaortic	region.	
The	detection	of	the	metastatic	SLN	in	the	second	case	is	an	
extremely	important	finding	and	is	a	crucial	argument	confirming	
the	 potential	 application	 of	 the	 SLNB	 into	 the	 treatment	
protocol.	In	this	patient	the	initial	diagnosis	was	the	endometroid	
adenocarcinoma	G1,	during	preoperative	evaluation	the	deepness	
of	 tumor	 invasion	 was	 less	 that	 50%	 of	 the	 myometrium	 so	
there	 were	 no	 indications	 for	 the	 lymphadenectomy.	 Even	 on	
macroscopic	 pathological	 examination	 the	 tumor	 invasion	
seemed	confined	to	the	internal	half	and	the	largest	diameter	of	
the	tumor	was	15mm.	Finally,	only	the	microscopic	evaluation	
revealed	tumor	invasion	of	more	than	50%	and	detected	grade	
2.	In	such	patient	the	nodal	status	after	initial	surgery	remains	
uncertain.	 Direct	 adjuvant	 radiotherapy	 without	 confirmation	
of	the	nodal	involvement	would	be	unreasonable	due	to	general	
low	incidence	of	nodal	metastases	–	this	would	probably	lead	to	
overtreatment.	For	the	same	reason	additional	surgery	in	most	
cases	would	not	provide	any	benefit	and	could	only	lead	to	higher	
morbidity	 due	 to	 high	 incidence	 of	 significant	 co-morbidites,	
advanced	 age	 and	 obesity.	 Thus	 this	 case	 clearly	 shows	 that	
the	 SLNB	 may	 improve	 the	 surgical	 staging	 in	 presumably	
“low	 risk”	 patients	 and	 decrease	 the	 unnecessary	 surgery	 or	
adjuvant	radiotherapy.	Moreover	the	SLN	might	be	send	for	the	
intraoperative	frozen	section	and	in	case	of	metastases	radical	
lymphadenectomy	 could	 be	 performed.	 On	 the	 margin,	 the	
randomized	studies	have	not	confirmed	therapeutic	impact	of	the	
pelvic	and	paraaortic	lymphadenectomy	thus	the	positive	SLN	
might	be	sufficient	reason	for	adjuvant	radiotherapy	[16,	17].	Of	
course,	this	is	only	a	hypothesis	which	needs	to	be	confirmed	in	
prospective	studies.	
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The	first	case	shows	also	potential	limitation	of	the	cervical	
administration.	 Previous	 cervical	 amputation	 caused	 almost	
complete	blocking	of	the	tracer	flow.	Although	such	cases	are	rare,	
this	type	of	the	surgery	should	be	regarded	as	contraindication	
for	the	cervical	approach	in	SLNB.
Another	 interesting	 aspect	 of	 the	 combined	 tracers	
administration	 used	 in	 our	 study	 is	 the	 presence	 of	 the	 SLNs	
that	are	both	hot	and	blue.	Despite	different	sites	of	the	tracers	
injection	such	SLNs	were	found	in	both	cases	(although	in	case	
no	 2	 with	 limited	 activity).	 This	 suggests	 that	 frequently	 the	
lymphatic	drainage	from	the	corpus	and	the	cervix	has	uniform	
route.	 This	 observation	 is	 concordant	 with	 studies	 analyzing	
the	 localization	of	 the	nodal	metastases	 in	endometrial	cancer	
mentioned	above	[14,	15].	
The	SPECT-CT	incorporated	to	the	SLNB	in	our	study	is	an	
useful	method	which	enables	precise	localization	of	the	potential	
SLN.	In	general,	most	of	the	necessary	data	regarding	the	SLNs	
location	 are	 provided	 with	 the	 planar	 lymphscintigraphy	 or	
the	SPECT	alone	but	 the	addition	of	 the	tomographic	 imaging	
enables	the	anatomical	localization	of	the	SLNs.	This	constitutes	
the	most	important	advantage	of	this	technique	which	prevents	
overlooking	the	SLNs	and	allows	less	extensive	tissue	preparation	
during	the	SLNB.	In	the	second	case	SPECT-CT	did	not	show	
any	 active	 spots	 although	 during	 the	 surgery	 we	 have	 found	
one	SLN	with	 sufficient	 activity	 (app.	 600	 cps).	The	potential	
explanation	 is	 that	 the	 tracer	uptake	was	 significantly	delayed	
due	to	impaired	lymphatic	drainage	(cervical	amputation),	and	
was	not	present	in	the	SLN	at	the	time	of	SPECT-CT.	
Conclusions
Presented	clinical	cases	confirms	that	SLNB	in	endometrial	
cancer	is	feasible	and	correctly	provides	information	about	the	
nodal	 status.	 The	 combined	 cervical	 and	 subserosal	 tracers	
administration	together	with	preoperative	SPECT-CT	constitute	
an	optimal	detection	method.	
References
  1. Wojciechowska U, Didkowska J, Zatoński W. Nowotwory złośliwe w Polsce w 2008 roku. 
Warszawa: Centrum Onkologii Instytut. 2010.
  2. Garbe C, Eigentler T. Diagnosis and treatment of cutaneous melanoma: state of the art 2006. 
Melanoma Res. 2007,17, 117–127. 
  3. Sato K, Shigenaga R, Ueda S, [et al.]. Sentinel lymph node biopsy for breast cancer. J Surg 
Oncol. 2007, 96, 322–329.
  4. Van der Zee A, Oonk M, De Hullu J, [et al.]. Sentinel node dissection is safe in the treatment of 
early-stage vulvar cancer. J Clin Oncol. 2008, 26, 884-889.
  5. Wydra D, Sawicki S, Wojtylak S, [et al.]. Sentinel node identification in cervical cancer patients 
undergoing transperitoneal radical hysterectomy: a study of 100 cases. Int J Gynecol Cancer. 
2006, 16, 649-654.
  6. Diaz J, Gemignani M, Pandit-Taskar N, [et al.]. Sentinel lymph node biopsy in the management 
of early-stage cervical carcinoma. Gynecol Oncol. 2011, 120, 347-352.
  7. Burke T, Levenback C, Tornos C, [et al.]. Intraabdominal lymphatic mapping to direct selective 
pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of 
a pilot study. Gynecol Oncol. 1996, 62, 169-173.
  8. Kang S, Yoo H, Hwang J, [et al.]. Sentinel lymph node biopsy in endometrial cancer: meta-
analysis of 26 studies. Gynecol Oncol. 2011, 123, 522-527. 
  9. Abu-Rustum N, Khoury-Collado F, Pandit-Taskar N, [et al.]. Sentinel lymph node mapping for 
grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol Oncol. 
2009, 113, 163-169. 
10. Ballester M, Dubernard G, Lécuru F, [et al.]. Detection rate and diagnostic accuracy of sentinel-
node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO) 
Lancet Oncol. 2011, 12, 469-476.
11. Case A, Rocconi R, Straughn J Jr, [et al.]. A prospective blinded evaluation of the accuracy of 
frozen section for the surgical management of endometrial cancer. Obstet Gynecol. 2006, 108, 
1375-1379.
12. Pandit-Taskar N, Gemignani M, Lyall A, [et al.]. Single photon emission computed tomography 
SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy. 
Gynecol Oncol. 2010, 117, 59-64. 
13. Robova H, Charvat M, Strnad P, [et al.]. Lymphatic mapping in endometrial cancer: comparison 
of hysteroscopic and subserosal injection and the distribution of sentinel lymph nodes. Int J 
Gynecol Cancer. 2009, 19, 391-394.
14. Abu-Rustum N, Gomez J, Alektiar K, [et al.]. The incidence of isolated paraaortic nodal 
metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. 
Gynecol Oncol. 2009, 115, 236-238. 
15. Hirahatake K, Hareyama H, Sakuragi N, [et al.]. A clinical and pathologic study on para-aortic 
lymph node metastasis in endometrial carcinoma. J Surg Oncol. 1997, 65, 82-87.
16. Kitchener H, Swart A, Qian Q, [et al.]. Efficacy of systematic pelvic lymphadenectomy in 
endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009, 373, 125-136. 
17. Panici P, Maggioni A, Hacker N, [et al.]. Systematic aortic and pelvic lymphadenectomy versus 
resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized 
clinical trial. J Natl Cancer Inst. 2005, 97, 560-566.
